Mirati Therapeutics, Inc.

Ownership Transactions Reported by 20 Insiders

Industry
Pharmaceutical Preparations
Location
3545 Cray Court, San Diego, California

Insiders trading volume in the past year

Mirati Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
EcoR1 Capital, LLC 10%+ Owner $437M Dec 18, 2023
David D. Meek Chief Executive Officer, Director $8.92M Jan 20, 2023
Laurie Stelzer Chief Financial Officer $6.04M Aug 9, 2023
S. Reed SVP, Chief Accounting Officer $907K Jan 14, 2022
Henry J. Fuchs Director $618K Jan 20, 2023
Craig A. Johnson Director Jan 23, 2024
Davis Aaron I. Director Jan 23, 2024
John B. Moriarty Chief Legal Officer Jan 23, 2024
Maria E. Martinez Director Jan 23, 2024
L. Carter Bruce Director Jan 23, 2024
Carol Giltner Gallagher Director Jan 23, 2024
Jamie Christensen EVP & Chief Scientific Officer -$322K Jan 23, 2024
Charles M. Baum Founder, President, and CEO, Director Jan 23, 2024
Benjamin Hickey EVP, Chief Commercial Officer -$343K Jan 23, 2024
Julie M. Cherrington Director Jan 23, 2024
Faheem Hasnain Director Jan 23, 2024
Shalini Sharp Director Jan 23, 2024
Aaron Ondrey Chief Financial Officer Jan 23, 2024
Alan B. Sandler Chief Medical Officer Jan 23, 2024
Boxer Capital, LLC Other* Jan 23, 2024

Recent Insider Transactions by Companies or Individuals for Mirati Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.